As of Sep 22
| +1.36 / +16.35%|
The 2 analysts offering 12-month price forecasts for Starpharma Holdings Ltd have a median target of 6.40, with a high estimate of 7.91 and a low estimate of 4.90. The median estimate represents a -33.84% decrease from the last price of 9.68.
The current consensus among 3 polled investment analysts is to Buy stock in Starpharma Holdings Ltd. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.